Insider · CIK 0001936158
Pao-Sheng Wei
Files at AIMD (Ainos, Inc.). First filing -, latest -.
In brief
Pao-Sheng Wei files SEC Form 4 as director at AIMD (Ainos, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Pao-Sheng Wei has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 13 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Nov 25, 2025 | AIMD Ainos, Inc. | AGrant or award Common Stock | +50,000 | $2.10 | $105k | 90,880 | Nov 26, 2025 |
| Nov 25, 2025 | AIMD Ainos, Inc. | AGrant or award RSUderivative | +50,000 | - | - | 0 | Nov 26, 2025 |
| Nov 25, 2025 | AIMD Ainos, Inc. | CConversion RSUderivative | -50,000 | - | - | 0 | Nov 26, 2025 |
| Mar 10, 2025 | AIMD Ainos, Inc. | AGrant or award Common Stock | +150,000 | $0.46 | $69k | 204,400 | Mar 12, 2025 |
| Mar 10, 2025 | AIMD Ainos, Inc. | AGrant or award RSUderivative | +150,000 | - | - | 0 | Mar 12, 2025 |
| Mar 10, 2025 | AIMD Ainos, Inc. | CConversion RSUderivative | -150,000 | - | - | 0 | Mar 12, 2025 |
| Jan 31, 2025 | AIMD Ainos, Inc. | AGrant or award Common Stock | +1,468 | $0.68 | $998 | 54,400 | Jan 31, 2025 |
| Jan 31, 2025 | AIMD Ainos, Inc. | AGrant or award RSUderivative | +1,468 | - | - | 1,468 | Jan 31, 2025 |
| Jan 31, 2025 | AIMD Ainos, Inc. | CConversion RSUderivative | -1,468 | - | - | 0 | Jan 31, 2025 |
| Jan 31, 2024 | AIMD Ainos, Inc. | AGrant or award Common Stock | +1,466 | $0.94 | $1,378 | 52,932 | Feb 2, 2024 |
| Jan 31, 2024 | AIMD Ainos, Inc. | CConversion RSUderivative | -1,466 | - | - | 1,466 | Feb 2, 2024 |
| Nov 24, 2023 | AIMD Ainos, Inc. | AGrant or award Common Stock | +250,000 | $0.60 | $150k | 257,333 | Nov 28, 2023 |
| Apr 7, 2023 | AIMD Ainos, Inc. | CConversion RSUderivative | -7,333 | - | - | 14,667 | Nov 28, 2023 |
Questions about Pao-Sheng Wei
Answered from the filings on this page, as of the latest one.
Is Pao-Sheng Wei buying or selling?
Pao-Sheng Wei has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Pao-Sheng Wei's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Pao-Sheng Wei has 0.
Where does Pao-Sheng Wei file Form 4?
Pao-Sheng Wei has filed Form 4 at AIMD (Ainos, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.